Product Code: GVR-2-68038-589-2
Colposcopy Market Growth & Trends:
The global colposcopy market size is expected to reach USD 761.2 million by 2030, registering a CAGR of 4.4% during the forecast period, according to a new report by Grand View Research, Inc.. Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth. According to the ICO Information Centre on HPV and Cancer, cervical cancer is the fourth most frequent cancer among women globally, with an estimated 604,127 new cases and 341,831 deaths in 2020.
An article published by the Human Papillomavirus Information Center stated that cervical cancer is reported to be the second most common cancer among women aged 15 to 44. Colposcopy helps in accurate identification of cervical pre-cancer and early invasive cancer. Moreover, colposcope directed biopsies of severe lesion visualized help in further management of the disease. Growing awareness and rise in the number of screening campaigns for cervical cancer conducted by governments of various regions are expected to fuel the market growth during the forecast period.
In the U.S., National Breast and Cervical Cancer Early Detection Program (NBCCEDP) offers breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured women across the country. Several obstacles arose as a result of the COVID-19 pandemic, including logistical constraints, low demand, and reduced sales and marketing activities. However, by mid-2022, the market is predicted to be steadily improving. By encouraging end-users to embrace high-end technologies for early diagnosis of the disease, aiming to lessen cervical cancer cases by 70%, and thus preventing over 4.5 million deaths (Source: WHO). This is expected to significantly boost the market in the coming years.
Colposcopy Market Report Highlights:
- The optical colposcopy segment dominated the market and is further expected to continue its dominance over the forecast period, as the adoption of optical colposcope is high in developing regions
- The video colposcopy segment is expected to grow at the fastest rate during the forecast period
- Based on application, the oral examination segment is expected to grow the fastest rate during the forecast period.
- Based on portability, the handheld segment is estimated to register the fastest growth rate during the forecast period, owing to its ease of use and compact nature
- The hospital segment held the largest revenue share based on end-use in 2022
- North America dominated the market and accounted for the largest revenue share in 2022
- In Asia Pacific, the market is anticipated to witness the fastest CAGR over the forecast period owing to the growing need for technologically advanced and cost-effective healthcare solutions
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Modality
- 1.1.2. Application
- 1.1.3. Portability
- 1.1.4. End-use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Application outlook
- 2.2.3. Portability outlook
- 2.2.4. End-use outlook
- 2.3. Competitive Insights
Chapter 3. Colposcopy Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.3.3. Market opportunity analysis
- 3.4. Colposcopy Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Colposcopy Market: Modality Estimates & Trend Analysis
- 4.1. Colposcopy Market: Key Takeaways
- 4.2. Colposcopy Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Optical
- 4.3.1. Optical market estimates and forecasts, 2017 to 2030 (USD Million)
- 4.4. Video
- 4.4.1. Video market estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 5. Colposcopy: Application Estimates & Trend Analysis
- 5.1. Colposcopy Market: Key Takeaways
- 5.2. Colposcopy Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Pelvic
- 5.3.1. Pelvic market estimates and forecasts, 2017 to 2030 (USD Million)
- 5.4. Oral
- 5.4.1. Oral market estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 6. Colposcopy: Portability Estimates & Trend Analysis
- 6.1. Colposcopy Market: Key Takeaways
- 6.2. Colposcopy Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Handheld
- 6.3.1. Handheld market estimates and forecasts, 2017 to 2030 (USD Million)
- 6.4. Stationary
- 6.4.1. Stationary market estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 7. Colposcopy: End-use Estimates & Trend Analysis
- 7.1. Colposcopy Market: Key Takeaways
- 7.2. Colposcopy Market: Movement & Market Share Analysis, 2022 & 2030
- 7.3. Hospitals
- 7.3.1. Hospitals market estimates and forecasts, 2017 to 2030 (USD Million)
- 7.4. Diagnostic Centers
- 7.4.1. Diagnostic centers market estimates and forecasts, 2017 to 2030 (USD Million)
- 7.5. Gynecology clinics
- 7.5.1. Gynecology clinics market estimates and forecasts, 2017 to 2030 (USD Million)
- 7.6. Specialty clinics
- 7.6.1. Specialty clinics market estimates and forecasts, 2017 to 2030 (USD Million)
- 7.7. Ambulatory surgical Centers
- 7.7.1. Ambulatory surgical Centers market estimates and forecasts, 2017 to 2030 (USD Million)
- 7.8. Research and academics
- 7.8.1. Research and academics estimates and forecasts, 2017 to 2030 (USD Million)
Chapter 8. Colposcopy Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. Colposcopy Market by Region: Key Takeaway
- 8.3. North America
- 8.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.3.3. Canada
- 8.3.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.2. Germany
- 8.4.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.3. France
- 8.4.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.4. Italy
- 8.4.4.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.5. Spain
- 8.4.5.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.6. Sweden
- 8.4.6.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.7. Norway
- 8.4.7.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.4.8. Denmark
- 8.4.8.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.5.2. China
- 8.5.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.5.3. India
- 8.5.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.5.4. Australia
- 8.5.4.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.5.5. Thailand
- 8.5.5.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.5.6. South Korea
- 8.5.6.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.6.2. Mexico
- 8.6.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.7. MEA
- 8.7.1. Saudi Arabia
- 8.7.1.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.7.3. UAE
- 8.7.3.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
- 8.7.4. Kuwait
- 8.7.4.1. Market estimates and forecasts, 2017 to 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company Profiles
- 9.2.1. Kaps GmbH & Co. KG
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. Carl Zeiss Meditec AG
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. CooperSurgical, Inc.
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. DYSIS Medical Inc.
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. ATMOS Medizin Technik GmbH & Co. KG
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. Olympus Corporation
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. McKesson Medical-Surgical Inc.
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Ecleris
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Optomic
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Seiler Instrument Inc.
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives